{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:45:00Z","timestamp":1793907900709,"version":"4.8.0"},"publisher-location":"Cham","reference-count":143,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319425405","type":"print"},{"value":"9783319425429","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-3-319-42542-9_9","type":"book-chapter","created":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T09:10:41Z","timestamp":1480583441000},"page":"155-176","source":"Crossref","is-referenced-by-count":52,"title":["Obesity and Ovarian Cancer"],"prefix":"10.1007","author":[{"given":"Shelley S.","family":"Tworoger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,2]]},"reference":[{"issue":"8","key":"9_CR1","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrc1408","volume":"4","author":"EE Calle","year":"2004","unstructured":"Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev 4(8):579\u2013591. doi: 10.1038\/nrc1408","journal-title":"Nat Rev"},{"issue":"8","key":"9_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrc3967","volume":"15","author":"AG Renehan","year":"2015","unstructured":"Renehan AG, Zwahlen M, Egger M (2015) Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer 15(8):484\u2013498. doi: 10.1038\/nrc3967","journal-title":"Nat Rev Cancer"},{"key":"9_CR3","unstructured":"The U.S. National Cancer Institute Obesity and Cancer Risk. http:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/obesity\/obesity-fact-sheet . Accessed 30 Nov 2015"},{"key":"9_CR4","unstructured":"American Cancer Society Does body weight affect cancer risk? http:\/\/www.cancer.org\/cancer\/cancercauses\/dietandphysicalactivity\/bodyweightandcancerrisk\/body-weight-and-cancer-risk-effects . Accessed 30 Nov 2015"},{"issue":"2","key":"9_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87\u2013108. doi: 10.3322\/caac.21262","journal-title":"CA Cancer J Clin"},{"issue":"17","key":"9_CR6","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1200\/jco.2012.45.5758","volume":"31","author":"HP Yang","year":"2013","unstructured":"Yang HP, Anderson WF, Rosenberg PS, Trabert B, Gierach GL, Wentzensen N, Cronin KA, Sherman ME (2013) Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States. J Clin Oncol (official journal of the American Society of Clinical Oncology) 31(17):2146\u20132151. doi: 10.1200\/jco.2012.45.5758","journal-title":"J Clin Oncol (official journal of the American Society of Clinical Oncology)"},{"issue":"5","key":"9_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1001\/jama.2012.39","volume":"307","author":"KM Flegal","year":"2012","unstructured":"Flegal KM, Carroll MD, Kit BK, Ogden CL (2012) Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999\u20132010. JAMA 307(5):491\u2013497. doi: 10.1001\/jama.2012.39","journal-title":"JAMA"},{"issue":"2","key":"9_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1365-2559.2007.02938.x","volume":"53","author":"EA Jarboe","year":"2008","unstructured":"Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP (2008) Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology 53(2):127\u2013138. doi: 10.1111\/j.1365-2559.2007.02938.x","journal-title":"Histopathology"},{"issue":"7121","key":"9_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nature05483","volume":"444","author":"ED Rosen","year":"2006","unstructured":"Rosen ED, Spiegelman BM (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444(7121):847\u2013853. doi: 10.1038\/nature05483","journal-title":"Nature"},{"issue":"4","key":"9_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1365-201X.2005.01468.x","volume":"184","author":"P Trayhurn","year":"2005","unstructured":"Trayhurn P (2005) Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 184(4):285\u2013293. doi: 10.1111\/j.1365-201X.2005.01468.x","journal-title":"Acta Physiol Scand"},{"key":"9_CR11","doi-asserted-by":"publisher","unstructured":"McTiernan A, Wu L, Chen C, Chlebowski R, Mossavar-Rahmani Y, Modugno F, Perri MG, Stanczyk FZ, Van Horn L, Wang CY (2006) Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity 14(9):1662\u20131677. doi: 10.1038\/oby.2006.191","DOI":"10.1038\/oby.2006.191"},{"issue":"2","key":"9_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/eje.0.1500161","volume":"150","author":"A Lukanova","year":"2004","unstructured":"Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, Mure A, Rinaldi S, Dossus L, Micheli A, Arslan A, Lenner P, Shore RE, Krogh V, Koenig KL, Riboli E, Berrino F, Hallmans G, Stattin P, Toniolo P, Kaaks R (2004) Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Euro J Endocrinol\/Eur Fed Endocr Soc 150(2):161\u2013171","journal-title":"Euro J Endocrinol\/Eur Fed Endocr Soc"},{"issue":"23","key":"9_CR13","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/jnci\/90.23.1774","volume":"90","author":"HA Risch","year":"1998","unstructured":"Risch HA (1998) Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90(23):1774\u20131786","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"9_CR14","first-page":"98","volume":"14","author":"A Lukanova","year":"2005","unstructured":"Lukanova A, Kaaks R (2005) Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 14(1):98\u2013107","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)"},{"issue":"1","key":"9_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ygyno.2004.03.026","volume":"94","author":"S Cunat","year":"2004","unstructured":"Cunat S, Hoffmann P, Pujol P (2004) Estrogens and epithelial ovarian cancer. Gynecol Oncol 94(1):25\u201332. doi: 10.1016\/j.ygyno.2004.03.026","journal-title":"Gynecol Oncol"},{"issue":"24","key":"9_CR16","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1001\/jama.1995.03530240036037","volume":"274","author":"KJ Helzlsouer","year":"1995","unstructured":"Helzlsouer KJ, Alberg AJ, Gordon GB, Longcope C, Bush TL, Hoffman SC, Comstock GW (1995) Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 274(24):1926\u20131930","journal-title":"JAMA"},{"issue":"6","key":"9_CR17","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1530\/erc-14-0282","volume":"21","author":"H Schock","year":"2014","unstructured":"Schock H, Surcel HM, Zeleniuch-Jacquotte A, Grankvist K, Lakso HA, Fortner RT, Kaaks R, Pukkala E, Lehtinen M, Toniolo P, Lundin E (2014) Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer. Endocr Relat Cancer 21(6):831\u2013844. doi: 10.1530\/erc-14-0282","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"9_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/ijc.10990","volume":"104","author":"A Lukanova","year":"2003","unstructured":"Lukanova A, Lundin E, Akhmedkhanov A, Micheli A, Rinaldi S, Zeleniuch-Jacquotte A, Lenner P, Muti P, Biessy C, Krogh V, Berrino F, Hallmans G, Riboli E, Kaaks R, Toniolo P (2003) Circulating levels of sex steroid hormones and risk of ovarian cancer. Int J Cancer 104(5):636\u2013642. doi: 10.1002\/ijc.10990","journal-title":"Int J Cancer"},{"issue":"5","key":"9_CR19","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1158\/1055-9965.epi-08-1214","volume":"18","author":"JL Hecht","year":"2009","unstructured":"Hecht JL, Kotsopoulos J, Hankinson SE, Tworoger SS (2009) Relationship between epidemiologic risk factors and hormone receptor expression in ovarian cancer: results from the Nurses\u2019 Health Study. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 18(5):1624\u20131630. doi: 10.1158\/1055-9965.epi-08-1214","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)"},{"issue":"3","key":"9_CR20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1001\/jama.288.3.334","volume":"288","author":"JV Lacey Jr","year":"2002","unstructured":"Lacey JV Jr, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, Schatzkin A, Schairer C (2002) Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA 288(3):334\u2013341","journal-title":"JAMA"},{"key":"9_CR21","doi-asserted-by":"publisher","unstructured":"Beral V, Bull D, Green J, Reeves G (2007) Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 369(9574):1703\u20131710. doi: 10.1016\/s0140-6736(07)60534-0","DOI":"10.1016\/s0140-6736(07)60534-0"},{"key":"9_CR22","doi-asserted-by":"publisher","unstructured":"Beral V, Gaitskell K, Hermon C, Moser K, Reeves G, Peto R (2015) Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet 385(9980):1835\u20131842. doi: 10.1016\/s0140-6736(14)61687-1","DOI":"10.1016\/s0140-6736(14)61687-1"},{"issue":"3","key":"9_CR23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/aje\/152.3.233","volume":"152","author":"RB Ness","year":"2000","unstructured":"Ness RB, Grisso JA, Klapper J, Schlesselman JJ, Silberzweig S, Vergona R, Morgan M, Wheeler JE (2000) Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid hormones and reproductions. Am J Epidemiol 152(3):233\u2013241","journal-title":"Am J Epidemiol"},{"issue":"3","key":"9_CR24","first-page":"419","volume":"83","author":"TP Gross","year":"1994","unstructured":"Gross TP, Schlesselman JJ (1994) The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer. Obstet Gynecol 83(3):419\u2013424","journal-title":"Obstet Gynecol"},{"issue":"5","key":"9_CR25","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/humupd\/dmu012","volume":"20","author":"JA Barry","year":"2014","unstructured":"Barry JA, Azizia MM, Hardiman PJ (2014) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 20(5):748\u2013758. doi: 10.1093\/humupd\/dmu012","journal-title":"Hum Reprod Update"},{"issue":"1","key":"9_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1158\/1055-9965.EPI-06-0755","volume":"16","author":"S Rinaldi","year":"2007","unstructured":"Rinaldi S, Dossus L, Lukanova A, Peeters PH, Allen NE, Key T, Bingham S, Khaw KT, Trichopoulos D, Trichopoulou A, Oikonomou E, Pera G, Larranaga N, Martinez-Garcia C, Ardanaz E, Quiros JR, Tormo MJ, Tjonneland A, Olsen A, Overvad K, Chang-Claude J, Linseisen J, Schulz M, Boeing H, van Gils CH, Bueno-de-Mesquita BH, Pala V, Palli D, Panico S, Tumino R, Vineis P, Clavel-Chapelon F, Mesrine S, Boutron-Ruault MC, Lundin E, Agren A, Berglund G, Manjer J, Kumle M, Lund E, Slimani N, Saracci R, Riboli E, Kaaks R (2007) Endogenous androgens and risk of epithelial ovarian cancer: results from the european prospective investigation into cancer and nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 16(1):23\u201329. doi: 10.1158\/1055-9965.EPI-06-0755","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"9_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/aje\/kwm278","volume":"167","author":"SS Tworoger","year":"2008","unstructured":"Tworoger SS, Lee IM, Buring JE, Hankinson SE (2008) Plasma androgen concentrations and risk of incident ovarian cancer. Am J Epidemiol 167(2):211\u2013218. doi: 10.1093\/aje\/kwm278","journal-title":"Am J Epidemiol"},{"issue":"4","key":"9_CR28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1677\/erc-08-0075","volume":"15","author":"CM Olsen","year":"2008","unstructured":"Olsen CM, Green AC, Nagle CM, Jordan SJ, Whiteman DC, Bain CJ, Webb PM (2008) Epithelial ovarian cancer: testing the \u2018androgens hypothesis\u2019. Endocr Relat Cancer 15(4):1061\u20131068. doi: 10.1677\/erc-08-0075","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"9_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ijc.29000","volume":"136","author":"J Ose","year":"2015","unstructured":"Ose J, Fortner RT, Rinaldi S, Schock H, Overvad K, Tjonneland A, Hansen L, Dossus L, Fournier A, Baglietto L, Romieu I, Kuhn E, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Masala G, Sieri S, Tumino R, Sacerdote C, Mattiello A, Ramon Quiros J, Obon-Santacana M, Larranaga N, Chirlaque MD, Sanchez MJ, Barricarte A, Peeters PH, Bueno-de-Mesquita HB, Onland-Moret NC, Brandstedt J, Lundin E, Idahl A, Weiderpass E, Gram IT, Lund E, Kaw KT, Travis RC, Merritt MA, Gunther MJ, Riboli E, Kaaks R (2015) Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer J Int Cancer 136(2):399\u2013410. doi: 10.1002\/ijc.29000","journal-title":"Int J Cancer J Int Cancer"},{"issue":"6","key":"9_CR30","first-page":"756","volume":"69","author":"M Resnicoff","year":"1993","unstructured":"Resnicoff M, Ambrose D, Coppola D, Rubin R (1993) Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab Invest (A Journal of Technical Methods and Pathology) 69(6):756\u2013760","journal-title":"Lab Invest (A Journal of Technical Methods and Pathology)"},{"issue":"8","key":"9_CR31","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1158\/1535-7163.mct-07-0070","volume":"6","author":"QS Ji","year":"2007","unstructured":"Ji QS, Mulvihill MJ, Rosenfeld-Franklin M, Cooke A, Feng L, Mak G, O\u2019Connor M, Yao Y, Pirritt C, Buck E, Eyzaguirre A, Arnold LD, Gibson NW, Pachter JA (2007) A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo. Mol Cancer Ther 6(8):2158\u20132167. doi: 10.1158\/1535-7163.mct-07-0070","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"9_CR32","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/ijc.10613","volume":"101","author":"A Lukanova","year":"2002","unstructured":"Lukanova A, Lundin E, Toniolo P, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, Zeleniuch-Jacquotte A, Berrino F, Hallmans G, Riboli E, Kaaks R (2002) Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer J Int Cancer 101(6):549\u2013554. doi: 10.1002\/ijc.10613","journal-title":"Int J Cancer J Int Cancer"},{"issue":"1","key":"9_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1677\/erc.1.01264","volume":"14","author":"PH Peeters","year":"2007","unstructured":"Peeters PH, Lukanova A, Allen N, Berrino F, Key T, Dossus L, Rinaldi S, van Gils CH, Bueno-de-Mesquita HB, Boeing H, Schulz M, Chang-Claude J, Linseisen J, Panico S, Sacerdote C, Palli D, Tumino R, Trichopoulou A, Trichopolos D, Bamia C, Larranaga N, Ardanaz E, Pera G, Quiros JR, Martinez-Garcia C, Navarro C, Bingham SA, Khaw KT, Clavel F, Tjonneland A, Olsen A, Overvad K, Tetsche MS, Lund E, Lundin E, Berglund G, Riboli E, Kaaks R (2007) Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the european prospective investigation into cancer and nutrition (EPIC). Endocr Relat Cancer 14(1):81\u201390. doi: 10.1677\/erc.1.01264","journal-title":"Endocr Relat Cancer"},{"issue":"8","key":"9_CR34","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1158\/1055-9965.epi-07-0319","volume":"16","author":"SS Tworoger","year":"2007","unstructured":"Tworoger SS, Lee IM, Buring JE, Pollak MN, Hankinson SE (2007) Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology) 16(8):1691\u20131695. doi: 10.1158\/1055-9965.epi-07-0319","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology)"},{"issue":"2","key":"9_CR35","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/ijc.29387","volume":"137","author":"H Schock","year":"2015","unstructured":"Schock H, Fortner RT, Surcel HM, Grankvist K, Pukkala E, Lehtinen M, Lundin E (2015) Early pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: a nested case-control study. Int J Cancer J Int Cancer 137(2):439\u2013447. doi: 10.1002\/ijc.29387","journal-title":"Int J Cancer J Int Cancer"},{"issue":"1","key":"9_CR36","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/bjc.2014.566","volume":"112","author":"J Ose","year":"2015","unstructured":"Ose J, Fortner RT, Schock H, Peeters PH, Onland-Moret NC, Bueno-de-Mesquita HB, Weiderpass E, Gram IT, Overvad K, Tjonneland A, Dossus L, Fournier A, Baglietto L, Trichopoulou A, Benetou V, Trichopoulos D, Boeing H, Masala G, Krogh V, Matiello A, Tumino R, Popovic M, Obon-Santacana M, Larranaga N, Ardanaz E, Sanchez MJ, Menendez V, Chirlaque MD, Travis RC, Khaw KT, Brandstedt J, Idahl A, Lundin E, Rinaldi S, Kuhn E, Romieu I, Gunter MJ, Merritt MA, Riboli E, Kaaks R (2015) Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort. Br J Cancer 112(1):162\u2013166. doi: 10.1038\/bjc.2014.566","journal-title":"Br J Cancer"},{"issue":"3\u20134","key":"9_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000081322","volume":"67","author":"L Dal Maso","year":"2004","unstructured":"Dal Maso L, Augustin LS, Franceschi S, Talamini R, Polesel J, Kendall CW, Jenkins DJ, Vidgen E, La Vecchia C (2004) Association between components of the insulin-like growth factor system and epithelial ovarian cancer risk. Oncology 67(3\u20134):225\u2013230. doi: 10.1159\/000081322","journal-title":"Oncology"},{"issue":"3","key":"9_CR38","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3892\/mco.2015.516","volume":"3","author":"Q Wang","year":"2015","unstructured":"Wang Q, Bian CE, Peng H, He L, Zhao X (2015) Association of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 with the risk of ovarian cancer: a systematic review and meta-analysis. Mol Clin Oncol 3(3):623\u2013628. doi: 10.3892\/mco.2015.516","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"9_CR39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ygyno.2004.10.012","volume":"96","author":"RA Sayer","year":"2005","unstructured":"Sayer RA, Lancaster JM, Pittman J, Gray J, Whitaker R, Marks JR, Berchuck A (2005) High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer. Gynecol Oncol 96(2):355\u2013361. doi: 10.1016\/j.ygyno.2004.10.012","journal-title":"Gynecol Oncol"},{"issue":"7","key":"9_CR40","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1210\/jcem.82.7.4085","volume":"82","author":"A Flyvbjerg","year":"1997","unstructured":"Flyvbjerg A, Mogensen O, Mogensen B, Nielsen OS (1997) Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor. J Clin Endocrinol Metab 82(7):2308\u20132313. doi: 10.1210\/jcem.82.7.4085","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9_CR41","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1210\/jcem.78.2.7508947","volume":"78","author":"A Karasik","year":"1994","unstructured":"Karasik A, Menczer J, Pariente C, Kanety H (1994) Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. J Clin Endocrinol Metab 78(2):271\u2013276. doi: 10.1210\/jcem.78.2.7508947","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9_CR42","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1158\/1078-0432.CCR-0672-2","volume":"10","author":"S Baron-Hay","year":"2004","unstructured":"Baron-Hay S, Boyle F, Ferrier A, Scott C (2004) Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer. Clin Cancer Res (An Official journal of the American Association for Cancer Research) 10(5):1796\u20131806","journal-title":"Clin Cancer Res (An Official journal of the American Association for Cancer Research)"},{"issue":"6","key":"9_CR43","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1053\/j.gastro.2007.03.059","volume":"132","author":"SE Shoelson","year":"2007","unstructured":"Shoelson SE, Herrero L, Naaz A (2007) Obesity, inflammation, and insulin resistance. Gastroenterology 132(6):2169\u20132180. doi: 10.1053\/j.gastro.2007.03.059","journal-title":"Gastroenterology"},{"issue":"1\u20132","key":"9_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mce.2005.09.014","volume":"247","author":"JS Fleming","year":"2006","unstructured":"Fleming JS, Beaugie CR, Haviv I, Chenevix-Trench G, Tan OL (2006) Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 247(1\u20132):4\u201321. doi: 10.1016\/j.mce.2005.09.014","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"9_CR45","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/gyno.1998.4974","volume":"69","author":"A Maccio","year":"1998","unstructured":"Maccio A, Lai P, Santona MC, Pagliara L, Melis GB, Mantovani G (1998) High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer. Gynecol Oncol 69(3):248\u2013252. doi: 10.1006\/gyno.1998.4974","journal-title":"Gynecol Oncol"},{"issue":"8","key":"9_CR46","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1002\/1097-0142(19931015)72:8<2433::AID-CNCR2820720822>3.0.CO;2-L","volume":"72","author":"MM Moradi","year":"1993","unstructured":"Moradi MM, Carson LF, Weinberg B, Haney AF, Twiggs LB, Ramakrishnan S (1993) Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer. Cancer 72(8):2433\u20132440","journal-title":"Cancer"},{"issue":"2","key":"9_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cyto.2012.01.015","volume":"58","author":"A Maccio","year":"2012","unstructured":"Maccio A, Madeddu C (2012) Inflammation and ovarian cancer. Cytokine 58(2):133\u2013147. doi: 10.1016\/j.cyto.2012.01.015","journal-title":"Cytokine"},{"issue":"3","key":"9_CR48","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ijgo.2004.12.015","volume":"88","author":"P Rzymski","year":"2005","unstructured":"Rzymski P, Opala T, Wilczak M, Wozniak J, Sajdak S (2005) Serum tumor necrosis factor alpha receptors p55\/p75 ratio and ovarian cancer detection. Int J Gynaecol Obstet 88(3):292\u2013298. doi: 10.1016\/j.ijgo.2004.12.015","journal-title":"Int J Gynaecol Obstet"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1471-2407-11-210","volume":"11","author":"D Lane","year":"2011","unstructured":"Lane D, Matte I, Rancourt C, Piche A (2011) Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients. BMC Cancer 11:210. doi: 10.1186\/1471-2407-11-210","journal-title":"BMC Cancer"},{"issue":"2","key":"9_CR50","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1158\/0008-5472.CAN-10-1496","volume":"71","author":"CW Lo","year":"2011","unstructured":"Lo CW, Chen MW, Hsiao M, Wang S, Chen CA, Hsiao SM, Chang JS, Lai TC, Rose-John S, Kuo ML, Wei LH (2011) IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer. Cancer Res 71(2):424\u2013434. doi: 10.1158\/0008-5472.CAN-10-1496","journal-title":"Cancer Res"},{"issue":"5","key":"9_CR51","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1158\/1055-9965.EPI-10-1180","volume":"20","author":"TV Clendenen","year":"2011","unstructured":"Clendenen TV, Lundin E, Zeleniuch-Jacquotte A, Koenig KL, Berrino F, Lukanova A, Lokshin AE, Idahl A, Ohlson N, Hallmans G, Krogh V, Sieri S, Muti P, Marrangoni A, Nolen BM, Liu M, Shore RE, Arslan AA (2011) Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomark Prev 20(5):799\u2013810. doi: 10.1158\/1055-9965.EPI-10-1180","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"9_CR52","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-1279-T","author":"J Ose","year":"2015","unstructured":"Ose J, Schock H, Tjonneland A, Hansen L, Overvad K, Dossus L, Clavel-Chapelon F, Baglietto L, Boeing H, Trichopolou A, Benetou V, Lagiou P, Masala G, Tagliabue G, Tumino R, Sacerdote C, Mattiello A, Bueno-de-Mesquita HB, Peeters PH, Onland-Moret NC, Weiderpass E, Gram IT, Sanchez S, Obon-Santacana M, Sanchez-Perez MJ, Larranaga N, Castano JM, Ardanaz E, Brandstedt J, Lundin E, Idahl A, Travis RC, Khaw KT, Rinaldi S, Romieu I, Merritt MA, Gunter MJ, Riboli E, Kaaks R, Fortner RT (2015) Inflammatory markers and risk of epithelial ovarian cancer by tumor subtypes: the EPIC cohort. Cancer Epidemiol Biomark Prev. doi: 10.1158\/1055-9965.EPI-14-1279-T","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8","key":"9_CR53","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/aje\/kwt098","volume":"178","author":"EM Poole","year":"2013","unstructured":"Poole EM, Lee IM, Ridker PM, Buring JE, Hankinson SE, Tworoger SS (2013) A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor alpha receptor 2 levels and risk of ovarian cancer. Am J Epidemiol 178(8):1256\u20131264. doi: 10.1093\/aje\/kwt098","journal-title":"Am J Epidemiol"},{"issue":"2","key":"9_CR54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ygyno.2014.08.025","volume":"135","author":"B Trabert","year":"2014","unstructured":"Trabert B, Pinto L, Hartge P, Kemp T, Black A, Sherman ME, Brinton LA, Pfeiffer RM, Shiels MS, Chaturvedi AK, Hildesheim A, Wentzensen N (2014) Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Gynecol Oncol 135(2):297\u2013304. doi: 10.1016\/j.ygyno.2014.08.025","journal-title":"Gynecol Oncol"},{"issue":"4","key":"9_CR55","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/01.AOG.0000257126.68803.03","volume":"109","author":"MA McSorley","year":"2007","unstructured":"McSorley MA, Alberg AJ, Allen DS, Allen NE, Brinton LA, Dorgan JF, Pollak M, Tao Y, Helzlsouer KJ (2007) C-reactive protein concentrations and subsequent ovarian cancer risk. Obstet Gynecol 109(4):933\u2013941. doi: 10.1097\/01.AOG.0000257126.68803.03","journal-title":"Obstet Gynecol"},{"issue":"8","key":"9_CR56","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/annonc\/mdq694","volume":"22","author":"AT Toriola","year":"2011","unstructured":"Toriola AT, Grankvist K, Agborsangaya CB, Lukanova A, Lehtinen M, Surcel HM (2011) Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study. Ann Oncol 22(8):1916\u20131921. doi: 10.1093\/annonc\/mdq694","journal-title":"Ann Oncol"},{"issue":"7","key":"9_CR57","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s10552-009-9330-2","volume":"20","author":"E Lundin","year":"2009","unstructured":"Lundin E, Dossus L, Clendenen T, Krogh V, Grankvist K, Wulff M, Sieri S, Arslan AA, Lenner P, Berrino F, Hallmans G, Zeleniuch-Jacquotte A, Toniolo P, Lukanova A (2009) C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy). Cancer Causes Control 20(7):1151\u20131159. doi: 10.1007\/s10552-009-9330-2","journal-title":"Cancer Causes Control"},{"issue":"4","key":"9_CR58","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.3390\/ijms14047742","volume":"14","author":"CE Pyragius","year":"2013","unstructured":"Pyragius CE, Fuller M, Ricciardelli C, Oehler MK (2013) Aberrant lipid metabolism: an emerging diagnostic and therapeutic target in ovarian cancer. Int J Mol Sci 14(4):7742\u20137756. doi: 10.3390\/ijms14047742","journal-title":"Int J Mol Sci"},{"issue":"5","key":"9_CR59","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3747\/co.v17i5.668","volume":"17","author":"M Tania","year":"2010","unstructured":"Tania M, Khan MA, Song Y (2010) Association of lipid metabolism with ovarian cancer. Curr Oncol 17(5):6\u201311","journal-title":"Curr Oncol"},{"issue":"11","key":"9_CR60","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0021-9681(86)90034-2","volume":"39","author":"RA Hiatt","year":"1986","unstructured":"Hiatt RA, Fireman BH (1986) Serum cholesterol and the incidence of cancer in a large cohort. J Chronic Dis 39(11):861\u2013870","journal-title":"J Chronic Dis"},{"issue":"1","key":"9_CR61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/jnci\/88.1.32","volume":"88","author":"KJ Helzlsouer","year":"1996","unstructured":"Helzlsouer KJ, Alberg AJ, Norkus EP, Morris JS, Hoffman SC, Comstock GW (1996) Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst 88(1):32\u201337","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"9_CR62","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1158\/1055-9965.EPI-12-0188","volume":"21","author":"JC Melvin","year":"2012","unstructured":"Melvin JC, Seth D, Holmberg L, Garmo H, Hammar N, Jungner I, Walldius G, Lambe M, Wigertz A, Van Hemelrijck M (2012) Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study. Cancer Epidemiol Biomark Prev 21(8):1381\u20131384. doi: 10.1158\/1055-9965.EPI-12-0188","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"9_CR63","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ygyno.2009.09.027","volume":"116","author":"AJ Li","year":"2010","unstructured":"Li AJ, Elmore RG, Chen IY, Karlan BY (2010) Serum low-density lipoprotein levels correlate with survival in advanced stage epithelial ovarian cancers. Gynecol Oncol 116(1):78\u201381. doi: 10.1016\/j.ygyno.2009.09.027","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9_CR64","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1006\/gyno.2001.6203","volume":"82","author":"A Ades","year":"2001","unstructured":"Ades A, Carvalho JP, Graziani SR, Amancio RF, Souen JS, Pinotti JA, Maranhao RC (2001) Uptake of a cholesterol-rich emulsion by neoplastic ovarian tissues. Gynecol Oncol 82(1):84\u201387. doi: 10.1006\/gyno.2001.6203","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9_CR65","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ygyno.2009.09.034","volume":"116","author":"DR Scoles","year":"2010","unstructured":"Scoles DR, Xu X, Wang H, Tran H, Taylor-Harding B, Li A, Karlan BY (2010) Liver X receptor agonist inhibits proliferation of ovarian carcinoma cells stimulated by oxidized low density lipoprotein. Gynecol Oncol 116(1):109\u2013116. doi: 10.1016\/j.ygyno.2009.09.034","journal-title":"Gynecol Oncol"},{"issue":"3","key":"9_CR66","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.ygyno.2013.05.025","volume":"130","author":"O Lavie","year":"2013","unstructured":"Lavie O, Pinchev M, Rennert HS, Segev Y, Rennert G (2013) The effect of statins on risk and survival of gynecological malignancies. Gynecol Oncol 130(3):615\u2013619. doi: 10.1016\/j.ygyno.2013.05.025","journal-title":"Gynecol Oncol"},{"issue":"4","key":"9_CR67","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1517\/14740331003662620","volume":"9","author":"DM Boudreau","year":"2010","unstructured":"Boudreau DM, Yu O, Johnson J (2010) Statin use and cancer risk: a comprehensive review. Expert Opin Drug Saf 9(4):603\u2013621. doi: 10.1517\/14740331003662620","journal-title":"Expert Opin Drug Saf"},{"key":"9_CR68","doi-asserted-by":"publisher","unstructured":"Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F, Webb PM (2007) Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. European journal of cancer (Oxford, England: 1990) 43(4):690\u2013709. doi: 10.1016\/j.ejca.2006.11.010","DOI":"10.1016\/j.ejca.2006.11.010"},{"issue":"8","key":"9_CR69","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1002\/ijc.29207","volume":"136","author":"D Aune","year":"2015","unstructured":"Aune D, Navarro Rosenblatt DA, Chan DS, Abar L, Vingeliene S, Vieira AR, Greenwood DC, Norat T (2015) Anthropometric factors and ovarian cancer risk: a systematic review and nonlinear dose-response meta-analysis of prospective studies. Int J Cancer J Int Cancer 136(8):1888\u20131898. doi: 10.1002\/ijc.29207","journal-title":"Int J Cancer J Int Cancer"},{"key":"9_CR70","doi-asserted-by":"publisher","unstructured":"Ovarian cancer and body size: individual participant meta-analysis including 25,157 women with ovarian cancer from 47 epidemiological studies (2012). PLoS medicine 9(4):e1001200. doi: 10.1371\/journal.pmed.1001200","DOI":"10.1371\/journal.pmed.1001200"},{"issue":"9","key":"9_CR71","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1023\/A:1012267619561","volume":"12","author":"DM Purdie","year":"2001","unstructured":"Purdie DM, Bain CJ, Webb PM, Whiteman DC, Pirozzo S, Green AC (2001) Body size and ovarian cancer: case-control study and systematic review (Australia). Cancer Causes Control (CCC) 12(9):855\u2013863","journal-title":"Cancer Causes Control (CCC)"},{"issue":"4","key":"9_CR72","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1158\/1055-9965.epi-07-2524","volume":"17","author":"LJ Schouten","year":"2008","unstructured":"Schouten LJ, Rivera C, Hunter DJ, Spiegelman D, Adami HO, Arslan A, Beeson WL, van den Brandt PA, Buring JE, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Hankinson SE, Lacey JV Jr, Leitzmann M, Lukanova A, Marshall JR, Miller AB, Patel AV, Rodriguez C, Rohan TE, Ross JA, Wolk A, Zhang SM, Smith-Warner SA (2008) Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 17(4):902\u2013912. doi: 10.1158\/1055-9965.epi-07-2524","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)"},{"key":"9_CR73","doi-asserted-by":"publisher","unstructured":"Kurian AW, Balise RR, McGuire V, Whittemore AS (2005) Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 96(2):520\u2013530. doi: 10.1016\/j.ygyno.2004.10.037","DOI":"10.1016\/j.ygyno.2004.10.037"},{"issue":"16","key":"9_CR74","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/jnci\/djg010","volume":"95","author":"A Engeland","year":"2003","unstructured":"Engeland A, Tretli S, Bjorge T (2003) Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 95(16):1244\u20131248","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"9_CR75","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1530\/erc-12-0395","volume":"20","author":"CM Olsen","year":"2013","unstructured":"Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Hogdall E, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Hoyo C, Moorman P, Weber RP, Cramer DW, Vitonis AF, Bandera EV, Olson SH, Rodriguez-Rodriguez L, King M, Brinton LA, Yang H, Garcia-Closas M, Lissowska J, Anton-Culver H, Ziogas A, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Webb PM (2013) Obesity and risk of ovarian cancer subtypes: evidence from the ovarian cancer association consortium. Endocr Relat Cancer 20(2):251\u2013262. doi: 10.1530\/erc-12-0395","journal-title":"Endocr Relat Cancer"},{"issue":"7630","key":"9_CR76","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1136\/bmj.39367.495995.AE","volume":"335","author":"GK Reeves","year":"2007","unstructured":"Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. BMJ (Clinical Research ed) 335(7630):1134. doi: 10.1136\/bmj.39367.495995.AE","journal-title":"BMJ (Clinical Research ed)"},{"key":"9_CR77","doi-asserted-by":"publisher","unstructured":"Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L (2014) Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 384(9945):755\u2013765. doi: 10.1016\/s0140-6736(14)60892-8","DOI":"10.1016\/s0140-6736(14)60892-8"},{"issue":"9612","key":"9_CR78","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569\u2013578. doi: 10.1016\/S0140-6736(08)60269-X","journal-title":"Lancet"},{"issue":"9","key":"9_CR79","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/sj.bjc.6602819","volume":"93","author":"K Rapp","year":"2005","unstructured":"Rapp K, Schroeder J, Klenk J, Stoehr S, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK (2005) Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 93(9):1062\u20131067. doi: 10.1038\/sj.bjc.6602819","journal-title":"Br J Cancer"},{"issue":"8","key":"9_CR80","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/ajcn\/34.8.1593","volume":"34","author":"AJ Stunkard","year":"1981","unstructured":"Stunkard AJ, Albaum JM (1981) The accuracy of self-reported weights. Am J Clin Nutr 34(8):1593\u20131599","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"9_CR81","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/oxfordjournals.aje.a113294","volume":"115","author":"M Palta","year":"1982","unstructured":"Palta M, Prineas RJ, Berman R, Hannan P (1982) Comparison of self-reported and measured height and weight. Am J Epidemiol 115(2):223\u2013230","journal-title":"Am J Epidemiol"},{"issue":"9","key":"9_CR82","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.ijo.0801375","volume":"24","author":"I Niedhammer","year":"2000","unstructured":"Niedhammer I, Bugel I, Bonenfant S, Goldberg M, Leclerc A (2000) Validity of self-reported weight and height in the French GAZEL cohort. Int J Obes Relat Metab Disord (Journal of the International Association for the Study of Obesity) 24(9):1111\u20131118","journal-title":"Int J Obes Relat Metab Disord (Journal of the International Association for the Study of Obesity)"},{"issue":"5","key":"9_CR83","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","volume":"164","author":"M Shih Ie","year":"2004","unstructured":"Shih Ie M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164(5):1511\u20131518","journal-title":"Am J Pathol"},{"issue":"2","key":"9_CR84","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/PGP.0b013e318161e4f5","volume":"27","author":"RJ Kurman","year":"2008","unstructured":"Kurman RJ, Shih Ie M (2008) Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol (Official Journal of the International Society of Gynecological Pathologists) 27(2):151\u2013160. doi: 10.1097\/PGP.0b013e318161e4f5","journal-title":"Int J Gynecol Pathol (Official Journal of the International Society of Gynecological Pathologists)"},{"issue":"5","key":"9_CR85","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/humrep\/des466","volume":"28","author":"MA Merritt","year":"2013","unstructured":"Merritt MA, De Pari M, Vitonis AF, Titus LJ, Cramer DW, Terry KL (2013) Reproductive characteristics in relation to ovarian cancer risk by histologic pathways. Hum Reprod (Oxford, England) 28(5):1406\u20131417. doi: 10.1093\/humrep\/des466","journal-title":"Hum Reprod (Oxford, England)"},{"issue":"4","key":"9_CR86","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/oxfordjournals.aje.a008937","volume":"144","author":"HA Risch","year":"1996","unstructured":"Risch HA, Marrett LD, Jain M, Howe GR (1996) Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol 144(4):363\u2013372","journal-title":"Am J Epidemiol"},{"issue":"12","key":"9_CR87","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","volume":"5","author":"M Kobel","year":"2008","unstructured":"Kobel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, Prentice LM, Miller D, Santos J, Swenerton K, Gilks CB, Huntsman D (2008) Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 5(12):e232. doi: 10.1371\/journal.pmed.0050232","journal-title":"PLoS Med"},{"issue":"12","key":"9_CR88","first-page":"1531","volume":"11","author":"R Kaaks","year":"2002","unstructured":"Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomark Prev 11(12):1531\u20131543","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"9_CR89","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.humpath.2009.04.017","volume":"40","author":"CB Gilks","year":"2009","unstructured":"Gilks CB, Prat J (2009) Ovarian carcinoma pathology and genetics: recent advances. Hum Pathol 40(9):1213\u20131223. doi: 10.1016\/j.humpath.2009.04.017","journal-title":"Hum Pathol"},{"issue":"3","key":"9_CR90","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.pgp.0000130446.84670.93","volume":"23","author":"CB Gilks","year":"2004","unstructured":"Gilks CB (2004) Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data. Int J Gynecol Pathol (Official Journal of the International Society of Gynecological Pathologists) 23(3):200\u2013205","journal-title":"Int J Gynecol Pathol (Official Journal of the International Society of Gynecological Pathologists)"},{"issue":"2","key":"9_CR91","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ijc.23509","volume":"123","author":"CM Olsen","year":"2008","unstructured":"Olsen CM, Nagle CM, Whiteman DC, Purdie DM, Green AC, Webb PM (2008) Body size and risk of epithelial ovarian and related cancers: a population-based case-control study. Int J Cancer J Int Cancer 123(2):450\u2013456. doi: 10.1002\/ijc.23509","journal-title":"Int J Cancer J Int Cancer"},{"issue":"10","key":"9_CR92","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1002\/ijc.24952","volume":"126","author":"PH Lahmann","year":"2010","unstructured":"Lahmann PH, Cust AE, Friedenreich CM, Schulz M, Lukanova A, Kaaks R, Lundin E, Tjonneland A, Halkjaer J, Severinsen MT, Overvad K, Fournier A, Chabbert-Buffet N, Clavel-Chapelon F, Dossus L, Pischon T, Boeing H, Trichopoulou A, Lagiou P, Naska A, Palli D, Grioni S, Mattiello A, Tumino R, Sacerdote C, Redondo ML, Jakszyn P, Sanchez MJ, Tormo MJ, Ardanaz E, Arriola L, Manjer J, Jirstrom K, Bueno-de-Mesquita HB, May AM, Peeters PH, Onland-Moret NC, Bingham S, Khaw KT, Allen NE, Spencer E, Rinaldi S, Slimani N, Chajes V, Michaud D, Norat T, Riboli E (2010) Anthropometric measures and epithelial ovarian cancer risk in the European prospective investigation into cancer and nutrition. Int J Cancer J Int Cancer 126(10):2404\u20132415. doi: 10.1002\/ijc.24952","journal-title":"Int J Cancer J Int Cancer"},{"key":"9_CR93","doi-asserted-by":"publisher","unstructured":"Kotsopoulos J, Baer HJ, Tworoger SS (2010) Anthropometric measures and risk of epithelial ovarian cancer: results from the nurses\u2019 health study. Obesity 18(8):1625\u20131631. doi: 10.1038\/oby.2009.461","DOI":"10.1038\/oby.2009.461"},{"issue":"3","key":"9_CR94","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/bjc.2013.384","volume":"109","author":"X Ma","year":"2013","unstructured":"Ma X, Beeghly-Fadiel A, Shu XO, Li H, Yang G, Gao YT, Zheng W (2013) Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women\u2019s Health Study. Br J Cancer 109(3):751\u2013755. doi: 10.1038\/bjc.2013.384","journal-title":"Br J Cancer"},{"key":"9_CR95","doi-asserted-by":"crossref","unstructured":"Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC (1990) Validity of self-reported waist and hip circumferences in men and women. Epidemiology 1(6):466\u2013473","DOI":"10.1097\/00001648-199011000-00009"},{"issue":"3","key":"9_CR96","doi-asserted-by":"crossref","first-page":"R314","DOI":"10.1186\/bcr998","volume":"7","author":"HJ Baer","year":"2005","unstructured":"Baer HJ, Colditz GA, Rosner B, Michels KB, Rich-Edwards JW, Hunter DJ, Willett WC (2005) Body fatness during childhood and adolescence and incidence of breast cancer in premenopausal women: a prospective cohort study. Breast Cancer Res 7(3):R314\u2013R325","journal-title":"Breast Cancer Res"},{"issue":"11","key":"9_CR97","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/aje\/kwq045","volume":"171","author":"HJ Baer","year":"2010","unstructured":"Baer HJ, Tworoger SS, Hankinson SE, Willett WC (2010) Body fatness at young ages and risk of breast cancer throughout life. Am J Epidemiol 171(11):1183\u20131194. doi: 10.1093\/aje\/kwq045","journal-title":"Am J Epidemiol"},{"issue":"3","key":"9_CR98","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/ijc.29427","volume":"137","author":"MM Dougan","year":"2015","unstructured":"Dougan MM, Hankinson SE, Vivo ID, Tworoger SS, Glynn RJ, Michels KB (2015) Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women. Int J Cancer J Int Cancer 137(3):625\u2013637. doi: 10.1002\/ijc.29427","journal-title":"Int J Cancer J Int Cancer"},{"key":"9_CR99","doi-asserted-by":"crossref","unstructured":"Kuper H, Cramer DW, Titus-Ernstoff L (2002) Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? Cancer Causes Control (CCC) 13(5):455\u2013463","DOI":"10.1023\/A:1015751105039"},{"issue":"4","key":"9_CR100","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10552-005-0416-1","volume":"17","author":"NB Peterson","year":"2006","unstructured":"Peterson NB, Trentham-Dietz A, Newcomb PA, Chen Z, Gebretsadik T, Hampton JM, Stampfer MJ, Willett WC, Egan KM (2006) Relation of anthropometric measurements to ovarian cancer risk in a population-based case-control study (United States). Cancer Causes Control (CCC) 17(4):459\u2013467. doi: 10.1007\/s10552-005-0416-1","journal-title":"Cancer Causes Control (CCC)"},{"issue":"11","key":"9_CR101","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/sj.bjc.6604742","volume":"99","author":"HJ Baer","year":"2008","unstructured":"Baer HJ, Hankinson SE, Tworoger SS (2008) Body size in early life and risk of epithelial ovarian cancer: results from the Nurses\u2019 Health Studies. Br J Cancer 99(11):1916\u20131922. doi: 10.1038\/sj.bjc.6604742","journal-title":"Br J Cancer"},{"issue":"5","key":"9_CR102","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.canep.2014.07.004","volume":"38","author":"CN Spracklen","year":"2014","unstructured":"Spracklen CN, Wallace RB, Sealy-Jefferson S, Robinson JG, Freudenheim JL, Wellons MF, Saftlas AF, Snetselaar LG, Manson JE, Hou L, Qi L, Chlebowski RT, Ryckman KK (2014) Birth weight and subsequent risk of cancer. Cancer Epidemiol 38(5):538\u2013543. doi: 10.1016\/j.canep.2014.07.004","journal-title":"Cancer Epidemiol"},{"issue":"9","key":"9_CR103","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1093\/annonc\/mdu214","volume":"25","author":"TO Yang","year":"2014","unstructured":"Yang TO, Reeves GK, Green J, Beral V, Cairns BJ (2014) Birth weight and adult cancer incidence: large prospective study and meta-analysis. Ann Oncol (Official Journal of the European Society for Medical Oncology\/ESMO) 25(9):1836\u20131843. doi: 10.1093\/annonc\/mdu214","journal-title":"Ann Oncol (Official Journal of the European Society for Medical Oncology\/ESMO)"},{"key":"9_CR104","doi-asserted-by":"publisher","unstructured":"Keum N, Greenwood DC, Lee DH, Kim R, Aune D, Ju W, Hu FB, Giovannucci EL (2015) Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst 107(2). doi: 10.1093\/jnci\/djv088","DOI":"10.1093\/jnci\/djv088"},{"issue":"12","key":"9_CR105","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1007\/s10552-010-9647-x","volume":"21","author":"AJ Canchola","year":"2010","unstructured":"Canchola AJ, Chang ET, Bernstein L, Largent JA, Reynolds P, Deapen D, Henderson KD, Ursin G, Horn-Ross PL (2010) Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort. Cancer Causes Control (CCC) 21(12):2241\u20132248. doi: 10.1007\/s10552-010-9647-x","journal-title":"Cancer Causes Control (CCC)"},{"issue":"5","key":"9_CR106","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/aje\/kwf224","volume":"157","author":"LJ Schouten","year":"2003","unstructured":"Schouten LJ, Goldbohm RA, van den Brandt PA (2003) Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol 157(5):424\u2013433","journal-title":"Am J Epidemiol"},{"issue":"2","key":"9_CR107","first-page":"288","volume":"100","author":"KM Fairfield","year":"2002","unstructured":"Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE, Hankinson SE (2002) Obesity, weight gain, and ovarian cancer. Obstet Gynecol 100(2):288\u2013296","journal-title":"Obstet Gynecol"},{"issue":"4","key":"9_CR108","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ijc.11266","volume":"106","author":"F Jonsson","year":"2003","unstructured":"Jonsson F, Wolk A, Pedersen NL, Lichtenstein P, Terry P, Ahlbom A, Feychting M (2003) Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish twin registry. Int J Cancer 106(4):594\u2013599","journal-title":"Int J Cancer"},{"issue":"8","key":"9_CR109","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s10552-005-3205-y","volume":"16","author":"C Hoyo","year":"2005","unstructured":"Hoyo C, Berchuck A, Halabi S, Bentley RC, Moorman P, Calingaert B, Schildkraut JM (2005) Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women. Cancer Causes Control (CCC) 16(8):955\u2013963. doi: 10.1007\/s10552-005-3205-y","journal-title":"Cancer Causes Control (CCC)"},{"issue":"10","key":"9_CR110","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1002\/cncr.21830","volume":"106","author":"JB Greer","year":"2006","unstructured":"Greer JB, Modugno F, Ness RB, Allen GO (2006) Anthropometry and the risk of epithelial ovarian cancer. Cancer 106(10):2247\u20132257. doi: 10.1002\/cncr.21830","journal-title":"Cancer"},{"issue":"1","key":"9_CR111","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GRF.0b013e31824b4611","volume":"55","author":"J Hunn","year":"2012","unstructured":"Hunn J, Rodriguez GC (2012) Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol 55(1):3\u201323. doi: 10.1097\/GRF.0b013e31824b4611","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"9_CR112","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/ajcn\/88.1.64","volume":"88","author":"SK Gao","year":"2008","unstructured":"Gao SK, Beresford SA, Frank LL, Schreiner PJ, Burke GL, Fitzpatrick AL (2008) Modifications to the Healthy Eating Index and its ability to predict obesity: the multi-ethnic study of atherosclerosis. Am J Clin Nutr 88(1):64\u201369","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"9_CR113","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3945\/jn.114.208785","volume":"145","author":"TT Fung","year":"2015","unstructured":"Fung TT, Pan A, Hou T, Chiuve SE, Tobias DK, Mozaffarian D, Willett WC, Hu FB (2015) Long-term change in diet quality is associated with body weight change in men and women. J Nutr 145(8):1850\u20131856. doi: 10.3945\/jn.114.208785","journal-title":"J Nutr"},{"issue":"25","key":"9_CR114","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1056\/NEJMoa1014296","volume":"364","author":"D Mozaffarian","year":"2011","unstructured":"Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB (2011) Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 364(25):2392\u20132404. doi: 10.1056\/NEJMoa1014296","journal-title":"N Engl J Med"},{"key":"9_CR115","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13048-014-0112-4","volume":"7","author":"J Xie","year":"2014","unstructured":"Xie J, Poole EM, Terry KL, Fung TT, Rosner BA, Willett WC, Tworoger SS (2014) A prospective cohort study of dietary indices and incidence of epithelial ovarian cancer. J Ovarian Res 7:112. doi: 10.1186\/s13048-014-0112-4","journal-title":"J Ovarian Res"},{"issue":"4","key":"9_CR116","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10552-011-9728-5","volume":"22","author":"U Chandran","year":"2011","unstructured":"Chandran U, Bandera EV, Williams-King MG, Paddock LE, Rodriguez-Rodriguez L, Lu SE, Faulkner S, Pulick K, Olson SH (2011) Healthy eating index and ovarian cancer risk. Cancer Causes Control (CCC) 22(4):563\u2013571. doi: 10.1007\/s10552-011-9728-5","journal-title":"Cancer Causes Control (CCC)"},{"issue":"3","key":"9_CR117","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/01635580701733091","volume":"60","author":"ET Chang","year":"2008","unstructured":"Chang ET, Lee VS, Canchola AJ, Dalvi TB, Clarke CA, Reynolds P, Purdie DM, Stram DO, West DW, Ziogas A, Bernstein L, Horn-Ross PL (2008) Dietary patterns and risk of ovarian cancer in the California Teachers Study cohort. Nutr Cancer 60(3):285\u2013291. doi: 10.1080\/01635580701733091","journal-title":"Nutr Cancer"},{"issue":"3","key":"9_CR118","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ygyno.2015.03.016","volume":"137","author":"RA Cannioto","year":"2015","unstructured":"Cannioto RA, Moysich KB (2015) Epithelial ovarian cancer and recreational physical activity: a review of the epidemiological literature and implications for exercise prescription. Gynecol Oncol 137(3):559\u2013573. doi: 10.1016\/j.ygyno.2015.03.016","journal-title":"Gynecol Oncol"},{"issue":"12","key":"9_CR119","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/jnci\/93.12.942","volume":"93","author":"ER Bertone","year":"2001","unstructured":"Bertone ER, Willett WC, Rosner BA, Hunter DJ, Fuchs CS, Speizer FE, Colditz GA, Hankinson SE (2001) Prospective study of recreational physical activity and ovarian cancer. J Natl Cancer Inst 93(12):942\u2013948","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"9_CR120","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1002\/cncr.20146","volume":"100","author":"JP Anderson","year":"2004","unstructured":"Anderson JP, Ross JA, Folsom AR (2004) Anthropometric variables, physical activity, and incidence of ovarian cancer: the Iowa Women\u2019s Health Study. Cancer 100(7):1515\u20131521. doi: 10.1002\/cncr.20146","journal-title":"Cancer"},{"issue":"12","key":"9_CR121","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s10552-010-9638-y","volume":"21","author":"F Chionh","year":"2010","unstructured":"Chionh F, Baglietto L, Krishnan K, English DR, MacInnis RJ, Gertig DM, Hopper JL, Giles GG (2010) Physical activity, body size and composition, and risk of ovarian cancer. Cancer Causes Control (CCC) 21(12):2183\u20132194. doi: 10.1007\/s10552-010-9638-y","journal-title":"Cancer Causes Control (CCC)"},{"key":"9_CR122","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.29834","author":"T Huang","year":"2015","unstructured":"Huang T, Eliassen AH, Hankinson SE, Okereke OI, Kubzansky LD, Wang M, Poole EM, Chavarro JE, Tworoger SS (2015) A prospective study of leisure-time physical activity and risk of incident epithelial ovarian cancer: Impact by menopausal status. Int J Cancer J Int Cancer. doi: 10.1002\/ijc.29834","journal-title":"Int J Cancer J Int Cancer"},{"issue":"2","key":"9_CR123","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.HYP.34.2.320","volume":"34","author":"M Soler","year":"1999","unstructured":"Soler M, Chatenoud L, Negri E, Parazzini F, Franceschi S, la Vecchia C (1999) Hypertension and hormone-related neoplasms in women. Hypertension 34(2):320\u2013325","journal-title":"Hypertension"},{"issue":"6","key":"9_CR124","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/ije\/dyr130","volume":"40","author":"T Bjorge","year":"2011","unstructured":"Bjorge T, Lukanova A, Tretli S, Manjer J, Ulmer H, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Jonsson H, Haggstrom C, Stattin P, Engeland A (2011) Metabolic risk factors and ovarian cancer in the metabolic syndrome and cancer project. Int J Epidemiol 40(6):1667\u20131677. doi: 10.1093\/ije\/dyr130","journal-title":"Int J Epidemiol"},{"issue":"4","key":"9_CR125","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF00052674","volume":"7","author":"AI Adler","year":"1996","unstructured":"Adler AI, Weiss NS, Kamb ML, Lyon JL (1996) Is diabetes mellitus a risk factor for ovarian cancer? A case-control study in Utah and Washington (United States). Cancer Causes Control (CCC) 7(4):475\u2013478","journal-title":"Cancer Causes Control (CCC)"},{"issue":"17","key":"9_CR126","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1001\/archinte.166.17.1871","volume":"166","author":"M Inoue","year":"2006","unstructured":"Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166(17):1871\u20131877. doi: 10.1001\/archinte.166.17.1871","journal-title":"Arch Intern Med"},{"issue":"11","key":"9_CR127","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1158\/1055-9965.epi-12-0867","volume":"21","author":"SM Gapstur","year":"2012","unstructured":"Gapstur SM, Patel AV, Diver WR, Hildebrand JS, Gaudet MM, Jacobs EJ, Campbell PT (2012) Type II diabetes mellitus and the incidence of epithelial ovarian cancer in the cancer prevention study-II nutrition cohort. Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology) 21(11):2000\u20132005. doi: 10.1158\/1055-9965.epi-12-0867","journal-title":"Cancer Epidemiol Biomark Prev (A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology)"},{"issue":"11","key":"9_CR128","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1038\/sj.bjc.6602611","volume":"92","author":"AJ Swerdlow","year":"2005","unstructured":"Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, Botha JL, Waugh NR, Morris AD, Gatling W, Gale EA, Patterson CC, Keen H (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92(11):2070\u20132075. doi: 10.1038\/sj.bjc.6602611","journal-title":"Br J Cancer"},{"issue":"6","key":"9_CR129","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/annonc\/mdn736","volume":"20","author":"AM Strasak","year":"2009","unstructured":"Strasak AM, Pfeiffer RM, Brant LJ, Rapp K, Hilbe W, Oberaigner W, Lang S, Borena W, Concin H, Diem G, Ruttmann E, Glodny B, Pfeiffer KP, Ulmer H (2009) Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study. Ann Oncol (Official Journal of the European Society for Medical Oncology\/ESMO) 20(6):1113\u20131120. doi: 10.1093\/annonc\/mdn736","journal-title":"Ann Oncol (Official Journal of the European Society for Medical Oncology\/ESMO)"},{"issue":"3","key":"9_CR130","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177(3):1053\u20131064. doi: 10.2353\/ajpath.2010.100105","journal-title":"Am J Pathol"},{"issue":"1","key":"9_CR131","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/jcp.24416","volume":"229","author":"D Califano","year":"2014","unstructured":"Califano D, Pignata S, Losito NS, Ottaiano A, Greggi S, De Simone V, Cecere S, Aiello C, Esposito F, Fusco A, Chiappetta G (2014) High HMGA2 expression and high body mass index negatively affect the prognosis of patients with ovarian cancer. J Cell Physiol 229(1):53\u201359. doi: 10.1002\/jcp.24416","journal-title":"J Cell Physiol"},{"issue":"2","key":"9_CR132","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ygyno.2007.06.010","volume":"107","author":"LM Hess","year":"2007","unstructured":"Hess LM, Barakat R, Tian C, Ozols RF, Alberts DS (2007) Weight change during chemotherapy as a potential prognostic factor for stage III epithelial ovarian carcinoma: a gynecologic oncology group study. Gynecol Oncol 107(2):260\u2013265. doi: 10.1016\/j.ygyno.2007.06.010","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9_CR133","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1447-0756.2011.01628.x","volume":"38","author":"DH Suh","year":"2012","unstructured":"Suh DH, Kim HS, Chung HH, Kim JW, Park NH, Song YS, Kang SB (2012) Body mass index and survival in patients with epithelial ovarian cancer. J Obstet Gynaecol Res 38(1):70\u201376. doi: 10.1111\/j.1447-0756.2011.01628.x","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"9_CR134","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ygyno.2014.01.030","volume":"133","author":"G Au-Yeung","year":"2014","unstructured":"Au-Yeung G, Webb PM, DeFazio A, Fereday S, Bressel M, Mileshkin L (2014) Impact of obesity on chemotherapy dosing for women with advanced stage serous ovarian cancer in the Australian ovarian cancer study (AOCS). Gynecol Oncol 133(1):16\u201322. doi: 10.1016\/j.ygyno.2014.01.030","journal-title":"Gynecol Oncol"},{"issue":"11","key":"9_CR135","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, Yamada SD, Peter ME, Gwin K, Lengyel E (2011) Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 17(11):1498\u20131503. doi: 10.1038\/nm.2492","journal-title":"Nat Med"},{"issue":"25","key":"9_CR136","doi-asserted-by":"crossref","first-page":"21100","DOI":"10.18632\/oncotarget.4228","volume":"6","author":"S Kato","year":"2015","unstructured":"Kato S, Abarzua-Catalan L, Trigo C, Delpiano A, Sanhueza C, Garcia K, Ibanez C, Hormazabal K, Diaz D, Branes J, Castellon E, Bravo E, Owen G, Cuello MA (2015) Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women. Oncotarget 6(25):21100\u201321119","journal-title":"Oncotarget"},{"issue":"2","key":"9_CR137","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12020-012-9788-7","volume":"43","author":"A Ptak","year":"2013","unstructured":"Ptak A, Kolaczkowska E, Gregoraszczuk EL (2013) Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells. Endocrine 43(2):394\u2013403. doi: 10.1007\/s12020-012-9788-7","journal-title":"Endocrine"},{"issue":"9","key":"9_CR138","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1097\/IGC.0b013e31822eb5f8","volume":"21","author":"HS Yang","year":"2011","unstructured":"Yang HS, Yoon C, Myung SK, Park SM (2011) Effect of obesity on survival of women with epithelial ovarian cancer: a systematic review and meta-analysis of observational studies. Int J Gynecol Cancer (Official Journal of the International Gynecological Cancer Society) 21(9):1525\u20131532. doi: 10.1097\/IGC.0b013e31822eb5f8","journal-title":"Int J Gynecol Cancer (Official Journal of the International Gynecological Cancer Society)"},{"key":"9_CR139","doi-asserted-by":"publisher","unstructured":"Protani MM, Nagle CM, Webb PM (2012) Obesity and ovarian cancer survival: a systematic review and meta-analysis. Cancer prevention research 5(7):901\u2013910. doi: 10.1158\/1940-6207.capr-12-0048","DOI":"10.1158\/1940-6207.capr-12-0048"},{"key":"9_CR140","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1757-2215-7-41","volume":"7","author":"HS Bae","year":"2014","unstructured":"Bae HS, Kim HJ, Hong JH, Lee JK, Lee NW, Song JY (2014) Obesity and epithelial ovarian cancer survival: a systematic review and meta-analysis. J Ovarian Res 7:41. doi: 10.1186\/1757-2215-7-41","journal-title":"J Ovarian Res"},{"issue":"5","key":"9_CR141","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/bjc.2015.245","volume":"113","author":"CM Nagle","year":"2015","unstructured":"Nagle CM, Dixon SC, Jensen A, Kjaer SK, Modugno F, deFazio A, Fereday S, Hung J, Johnatty SE, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Van Nieuwenhuysen E, Lambrechts S, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Chang-Claude J, Goodman MT, Ness RB, Moysich K, Heitz F, du Bois A, Harter P, Schwaab I, Matsuo K, Hosono S, Goode EL, Vierkant RA, Larson MC, Fridley BL, Hogdall C, Schildkraut JM, Weber RP, Cramer DW, Terry KL, Bandera EV, Paddock L, Rodriguez-Rodriguez L, Wentzensen N, Yang HP, Brinton LA, Lissowska J, Hogdall E, Lundvall L, Whittemore A, McGuire V, Sieh W, Rothstein J, Sutphen R, Anton-Culver H, Ziogas A, Pearce CL, Wu AH, Webb PM (2015) Obesity and survival among women with ovarian cancer: results from the ovarian cancer association consortium. Br J Cancer 113(5):817\u2013826. doi: 10.1038\/bjc.2015.245","journal-title":"Br J Cancer"},{"issue":"4","key":"9_CR142","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/igc.0000000000000388","volume":"25","author":"A Smits","year":"2015","unstructured":"Smits A, Lopes A, Das N, Bekkers R, Galaal K (2015) Quality of life in ovarian cancer survivors: the influence of obesity. Int J Gynecol Cancer (Official Journal of the International Gynecological Cancer Society) 25(4):616\u2013621. doi: 10.1097\/igc.0000000000000388","journal-title":"Int J Gynecol Cancer (Official Journal of the International Gynecological Cancer Society)"},{"key":"9_CR143","doi-asserted-by":"publisher","unstructured":"Smits A, Smits E, Lopes A, Das N, Hughes G, Talaat A, Pollard A, Bouwman F, Massuger L, Bekkers R, Galaal K (2015) Body mass index, physical activity and quality of life of ovarian cancer survivors: time to get moving? Gynecol Oncol 139(1):148\u2013154. doi: 10.1016\/j.ygyno.2015.08.005","DOI":"10.1016\/j.ygyno.2015.08.005"}],"container-title":["Recent Results in Cancer Research","Obesity and Cancer"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-42542-9_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T20:40:51Z","timestamp":1657917651000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-42542-9_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319425405","9783319425429"],"references-count":143,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-42542-9_9","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}